secwatch.observer — SEC 8-K summary
======================================

Issuer:     Guardant Health, Inc. (GH)
CIK:        0001576280
Form:       8-K
Filed at:   2024-05-31T23:59:59+00:00
Accession:  0001193125-24-151836
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Guardant Health amends executive severance plan with enhanced benefits for Co-CEOs
--------------------------------------------------------------------------------

- Amendment approved May 24, 2024; applies to all executives including named officers.
- Non-CIC termination: 12 months base salary (lump sum), prorated target bonus, 12 months COBRA.
- CIC termination: 18 months salary (24 for Co-CEOs), full target bonus, full equity vesting.
- Co-CEOs' 2024 long-term awards vest fully on termination before 2026; PSUs vest at up to 250% target if CIC before 2025.
- Co-CEOs receive annual RSU/PSU awards in lieu of salary and bonus; severance reflected in accelerated vesting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1576280/000119312524151836/0001193125-24-151836-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1576280/000119312524151836/d809302d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-151836

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer